| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000230333.2 |
Ponatinib |
Brain lower grade glioma |
0.033053795 |
Resistant |
| ENSG00000230333.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.009474144 |
Resistant |
| ENSG00000230333.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.036894368 |
Resistant |
